{"id":"W4402104070","doi":"10.1016/j.jaad.2024.07.102","title":"52661 Bimekizumab 4-year maintenance of responses in Week 16 responders with moderate to severe plaque psoriasis: Results from the BE BRIGHT open label extension phase 3 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Plaque psoriasis; Open label; Psoriasis; Dermatology; Clinical trial; Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00188691,0.001311686,0.002773895,0.0003244959,0.0004290927,0.001339627,0.0008009032,0.001334625,0.006065822],"category_scores_gemma":[0.0009038876,0.0005157684,0.001989357,0.0003055295,0.0008153901,0.001134219,0.0003440488,0.004354811,0.002009709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006829694,"about_ca_system_score_gemma":0.0008878764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000840687,"about_ca_topic_score_gemma":0.00159262,"domain_scores_codex":[0.9994144,0.0002171191,0.00002078623,0.00007464508,0.00005417557,0.0002188136],"domain_scores_gemma":[0.9992955,0.0001376201,0.000166492,0.00007218716,0.00003672046,0.0002914819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8919322,0.0140488,0.001894352,0.0006706053,0.0009779332,0.000111342,0.0001341566,0.001050778,0.01099697,0.0002281198,0.005297912,0.0726569],"study_design_scores_gemma":[0.8021988,0.1813437,0.01150451,0.00007172301,0.00050282,0.0001588894,0.00005594547,0.0006985716,0.001005399,0.0002554251,0.002165793,0.00003847449],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889318,0.004734895,0.0003760309,0.000797904,0.0002977278,0.0007608479,0.001251947,0.0001775547,0.002671395],"genre_scores_gemma":[0.9852508,0.002504305,0.0008879273,0.001550561,0.0003619982,0.001189448,0.002082066,0.00005871934,0.006114137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006065822,"threshold_uncertainty_score":0.02029216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04807477098685396,"score_gpt":0.3270443143535715,"score_spread":0.2789695433667175,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}